Phenobarbital NDC 13517-693

NDC codes

FDA NDC Directory

Product NDC (as listed)13517-693Labeler and product segments. Claims need a package NDC.

Product NDC at billing width13517-0693Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
13517-693-01	13517069301	100 TABLET in 1 BOTTLE, PLASTIC (13517-693-01)Marketed from Nov 30, 2022
13517-693-05	13517069305	500 TABLET in 1 BOTTLE, PLASTIC (13517-693-05)Marketed from Nov 30, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phenobarbital
Generic name (nonproprietary): phenobarbital
Active ingredients: Phenobarbital — 60 mg/1
Dosage form: Tablet
Route: Oral
Labeler: e5 Pharma, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Nov 30, 2022
Marketing end: Nov 30, 2026
DEA schedule: CIV
Identifiers: Product ID 13517-693_8d7c438d-0331-441f-848f-b832658a8728SPL ID 8d7c438d-0331-441f-848f-b832658a8728SPL set ID 5c4efd5a-75be-480b-ac31-40dd66feada1RxCUI 198083, 198089, 312357, 312362UNII YQE403BP4DUPC 0313517693017, 0313517694014, 0313517691013, 0313517692010

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N413517069301 followed by a unit qualifier and the quantity

Package 13517-0693-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 31, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sedative Anticonvulsant – For the treatment of generalized and partial seizures.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)